Digital PCR Market to Exhibit 17.2% CAGR by 2026 Owing to Improving Healthcare Facilities in Developing Nations, reports Fortune Business Insights™

    NEXT STORY
    Sun BioPharma Announces Pause in Enrollment of Clinical Trial of SBP-101 for Patients with Pancreatic Cancer
    PREV STORY
    SIGA Announces Award of First International Contract for Oral TPOXX® with Purchase by the Canadian Department of National Defence
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    The Myriad myPath® Melanoma Test Effectively Diagnosed Patients in the Largest Outcomes-Based Study for a Melanoma Diagnostic

    SALT LAKE CITY, Oct. 27, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a ...

    author_avatar
    NASDAQ Market News

    NewLink Genetics Appoints Eugene Kennedy, M.D. as Chief Medical Officer

    AMES, Iowa, Nov. 14, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced ...

    author_avatar
    NASDAQ Market News

    Cesca Therapeutics to Announce Financial Results for the Three Months Ended September 30, 2017 and Host Conference Call on November 14th

    RANCHO CORDOVA, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a ...

    author_avatar
    NASDAQ Market News